234 related articles for article (PubMed ID: 3938813)
1. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Sawada Y; Hanano M; Sugiyama Y; Iga T
J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
[TBL] [Abstract][Full Text] [Related]
2. Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats.
Chiou WL; Hsu FH
Pharm Res; 1988 Oct; 5(10):668-72. PubMed ID: 3244621
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the volumes of distribution of basic drugs in humans based on data from animals.
Sawada Y; Hanano M; Sugiyama Y; Harashima H; Iga T
J Pharmacokinet Biopharm; 1984 Dec; 12(6):587-96. PubMed ID: 6533294
[TBL] [Abstract][Full Text] [Related]
4. Drug kinetics and alcohol ingestion.
Sellers EM; Holloway MR
Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
[TBL] [Abstract][Full Text] [Related]
5. Drug concentration in saliva.
Mucklow JC; Bending MR; Kahn GC; Dollery CT
Clin Pharmacol Ther; 1978 Nov; 24(5):563-70. PubMed ID: 29738
[TBL] [Abstract][Full Text] [Related]
6. Prediction of serum concentration time course of quinidine in human using a physiologically based pharmacokinetic model developed from the rat.
Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacobiodyn; 1986 Feb; 9(2):132-8. PubMed ID: 3712213
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the plasma concentration time courses of various drugs in humans based on data from rats.
Sawada Y; Harashima H; Hanano M; Sugiyama Y; Iga T
J Pharmacobiodyn; 1985 Sep; 8(9):757-66. PubMed ID: 4087135
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
Van Peer A; Belpaire F; Bogaert M
Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic drug interactions with propranolol.
Wood AJ; Feely J
Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
[TBL] [Abstract][Full Text] [Related]
10. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG
Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595
[TBL] [Abstract][Full Text] [Related]
11. Interindividual differences in rates of drug oxidation in man.
Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
[No Abstract] [Full Text] [Related]
12. Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
Humphries TJ
Dig Dis Sci; 1991 Dec; 36(12):1665-9. PubMed ID: 1748033
[TBL] [Abstract][Full Text] [Related]
13. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
O'Leary TD; Sansom LN
J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
[TBL] [Abstract][Full Text] [Related]
14. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
15. Application of stable labelled drugs in clinical pharmacokinetic investigations.
Eichelbaum M; von Unruh GE; Somogyi A
Clin Pharmacokinet; 1982; 7(6):490-507. PubMed ID: 6819104
[No Abstract] [Full Text] [Related]
16. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Shrewsbury RP
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
[TBL] [Abstract][Full Text] [Related]
17. Liver disease and drug therapy.
Black M
Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
[No Abstract] [Full Text] [Related]
18. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
19. [Alcohol and drugs].
De Baere H
Tijdschr Gastroenterol; 1976; 19(2):117-23. PubMed ID: 1013984
[No Abstract] [Full Text] [Related]
20. Drug pharmacokinetics in thyroid dysfunction.
Rodighiero V
Minerva Endocrinol; 1985; 10(2):97-113. PubMed ID: 2415808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
